- Investor's Business Daily•4 days ago
Galenica, whose joint venture with Fresenius has rights to Relypsa's drug Veltassa, is taking full ownership.
|Bid||32.00 x 100|
|Ask||44.47 x 100|
|52wk Range||36.89 - 45.85|
|Day's Range||44.31 - 44.65|
|Avg Vol (3m)||163,117|
As of 4:02 PM EDT. Market closed.